Potential bias in ophthalmic pharmaceutical clinical trials

Potential bias in ophthalmic pharmaceutical clinical trials

Paul VarnerJohn J Pershing Veterans&rsquo; Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the st...

Full description

Bibliographic Details
Main Author:	Paul Varner
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-06-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/potential-bias-in-ophthalmic-pharmaceutical-clinical-trials-a1795

Similar Items

Pharmaceutically Relevant Microemulsions with Potential Topical, Ophthalmic, and Parenteral Applications
by: Zachar, Carrie L.
Published: (2010)

Evaluation of web-based annotation of ophthalmic images for multicentric clinical trials
by: Chalam K, et al.
Published: (2006-01-01)

Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs
by: Elisa Chilet-Rosell
Published: (2014-12-01)

Applications of Polymeric and Lipid Nanoparticles in Ophthalmic Pharmaceutical Formulations: Present and Future Considerations
by: Hugo Almeida, et al.
Published: (2014-07-01)

Recent Advances and the Potential for Clinical Use of Autofluorescence Detection of Extra-Ophthalmic Tissues
by: Jonas Wizenty, et al.
Published: (2020-04-01)

Biases in clinical trials with sequential monitoring
by: Schou Manjula, et al.
Published: (2011-12-01)

Ophthalmic clinical officers: developments in Uganda
by: Godfrey Kaggwa
Published: (2014-07-01)

Development and validation of analytical method by HPLC-DAD for determination of vasodilator active in pharmaceutical ophthalmic forms
by: Aina Liz Alves Cesar, et al.
Published: (2020-08-01)

Tackling publication bias in clinical trial reporting.
Published: (2005-10-01)

Clinical Application of Ophthalmic Implant Materials and Biocompatibility
by: Ke Feng, et al.
Published: (2017-01-01)

Ophthalmic photographer virtual clinics in medical retina
by: Abdul R El-Khayat, et al.
Published: (2020-04-01)

The role of difluprednate ophthalmic emulsion in clinical practice
by: Karim N Jamal, et al.
Published: (2009-06-01)

Ophthalmic manifestations in the COVID-19 clinical spectrum
by: K Kiran Kumar, et al.
Published: (2021-01-01)

Clinical Features of the Ophthalmic Status in Pregnant Women
by: V. N. Trubilin, et al.
Published: (2018-03-01)

POLYNEOPLASMS IN OPHTHALMIC ONCOLOGY: CLINICAL AND EPIDEMIOLOGICAL ASPECTS
by: I. Ye. Panova, et al.
Published: (2015-04-01)

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program
by: Clara C Chan, et al.
Published: (2019-01-01)

The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials
by: Dat T Tran, et al.
Published: (2018-01-01)

REQUIREMENTS ON CLINICAL TRIALS FOR VETERINARY PHARMACEUTICAL PRODUCTS FOR FISH
by: Simona Sturzu, et al.
Published: (2016-12-01)

Correlates of the Quality of Pharmaceutical Clinical Trials Paper in Taiwan
by: Wei-Shun Chang, et al.
Published: (2016)

Mechanisms and direction of allocation bias in randomised clinical trials
by: Asger Paludan-Müller, et al.
Published: (2016-10-01)

Varied ophthalmic manifestations in COVID 19 clinical spectrum
by: Kirandeep Kaur, et al.
Published: (2021-01-01)

The International Council of Ophthalmology Ophthalmic clinical evaluation exercise
by: Ana G Palis, et al.
Published: (2021-01-01)

Central corneal thickness: Important considerate in ophthalmic clinic
by: Sneha Thakur, et al.
Published: (2020-01-01)

Clinical observation on superselective ophthalmic artery chemotherapy for retinoblastoma
by: Chang-Fu Peng, et al.
Published: (2013-12-01)

Clinical study of headache with special reference to ophthalmic cause
by: Shashi Jain, et al.
Published: (2015)

Ophthalmic practice
by: Sue Stevens
Published: (2005-01-01)

Ophthalmic practice
by: Sue Stevens
Published: (2005-03-01)

Multistage Stochastic Programming Models for Pharmaceutical Clinical Trial Planning
by: Zuo Zeng, et al.
Published: (2017-11-01)

Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
by: John D. Sheppard, et al.
Published: (2019-02-01)

Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship.
by: John M McPartland
Published: (2009-01-01)

Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial
by: Toshida H, et al.
Published: (2017-06-01)

The role of technology in avoiding bias in the design and execution of clinical trials
by: Goodale H, et al.
Published: (2013-01-01)

Selection bias in clinical stroke trials depending on ability to consent
by: Benjamin Hotter, et al.
Published: (2017-12-01)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
by: Bruce I Gaynes, et al.
Published: (2008-06-01)

Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens
by: Comstock TL, et al.
Published: (2014-04-01)

Microbial Contamination of Extended Use Ophthalmic Drops in Ophthalmology Clinic
by: Chua SW, et al.
Published: (2021-07-01)

Clinical Features of Optic Disc Drusen in an Ophthalmic Genetics Cohort
by: Jasmine Y. Serpen, et al.
Published: (2020-01-01)

The Maintenance and Repair of Ophthalmic Surgical Instruments: Training at the Eye Clinic
by: Danny Haddad, et al.
Published: (2002-01-01)

Clinical evaluation of tromaril as an anti-inflammatory agent in ophthalmic practice
by: Albal M, et al.
Published: (1983-12-01)

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
by: Daoud Al-Badriyeh, et al.
Published: (2010-05-01)